Related Experiment Video
Updated: Jun 1, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
[Psoriasis and obesity: a review and practical recommendations]
M M Farías1, V Serrano, C de la Cruz
1Departamento de Nutrición, Pontificia Universidad Católica de Chile, Santiago, Chile. mmfarias@gmail.com
Actas Dermo-Sifiliograficas
|May 24, 2011
Summary
Patients with psoriasis face a higher risk of obesity due to shared inflammation pathways. Managing psoriasis effectively requires addressing the patient's metabolic health, including weight management.
Area of Science:
- Dermatology and Metabolic Health
- Immunoinflammatory Diseases
Context:
- Psoriasis is increasingly linked to metabolic disorders, especially obesity.
- Obesity exacerbates psoriasis severity and impacts treatment efficacy.
- Shared chronic low-grade inflammation underlies the psoriasis-obesity connection.
Purpose:
- To review current literature on the relationship between psoriasis and obesity.
- To provide practical recommendations for dermatologic management.
- To highlight the importance of considering metabolic health in psoriasis patients.
Summary:
- Epidemiological data confirm a higher risk of metabolic disorders, particularly obesity, in psoriasis patients.
- Obesity is associated with increased psoriasis incidence, severity, and poorer treatment response.
- Management strategies must integrate metabolic assessment, including lifestyle and dietary advice.
Impact:
- Informs dermatologists to adopt a holistic approach to psoriasis care.
- Emphasizes the need for targeted interventions for obesity in psoriasis patients.
- Aims to improve patient outcomes by addressing comorbid metabolic conditions.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...